Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare
Ticker
Company
Zen Rating
Financials
Market Cap
ROE
ROA
ROCE
ROIC
D/E
Current Ratio
Gross Margin
Profit Margin
Operating Margin
HBIO
HARVARD BIOSCIENCE INC
$24.90M-73.00%-12.40%-7.50%-7.10%6.761.9958.40%-11.40%-4.74%
LXRX
LEXICON PHARMACEUTICALS INC
$990.56M-18.60%-11.80%-6.95%-12.50%0.3318.8099.50%-37.50%-25.84%
TXG
10X GENOMICS INC
$3.13B-2.90%-2.20%-2.13%-4.10%0.255.9069.60%-3.50%-3.01%
CRL
CHARLES RIVER LABORATORIES INTERNATIONAL INC
$7.65B-5.70%-2.50%-0.92%-1.10%1.611.3632.30%-4.60%-1.52%
MTD
METTLER TOLEDO INTERNATIONAL INC
$22.04B-610.30%24.50%43.95%31.60%-88.601.2059.20%21.40%27.52%
MDT
MEDTRONIC PLC
$100.34B9.50%5.00%7.62%11.40%0.862.5464.90%13.00%17.61%
URGN
UROGEN PHARMA LTD
$1.46BN/A-62.80%-60.50%-59.20%-3.044.6989.90%-94.80%-87.44%
HCA
HCA HEALTHCARE INC
$87.09B-123.20%11.30%26.21%13.90%-10.220.8341.60%8.90%14.47%
BTMD
BIOTE CORP
$77.79M-22.90%15.10%50.43%23.10%-2.441.2970.10%8.30%16.30%
AORT
ARTIVION INC
$1.11B2.70%1.30%5.28%7.30%0.963.8664.60%2.50%9.09%
PTN
PALATIN TECHNOLOGIES INC
$25.67M-141.40%-58.10%-58.39%260.00%0.255.04100.00%-48.50%-48.45%
NPCE
NEUROPACE INC
$555.05M-120.70%-20.60%-17.82%-10.70%5.845.3878.30%-21.70%-14.81%
ANAB
ANAPTYSBIO INC
$1.76BN/A-7.80%-9.25%-5.80%24.867.58100.00%-11.50%-11.46%
NRC
NRC HEALTH
$429.10M57.30%6.60%20.42%18.40%8.970.5261.80%6.50%14.15%
BAX
BAXTER INTERNATIONAL INC
$9.83B-16.40%-5.40%-2.38%-2.50%2.291.8530.10%-9.70%-3.40%
DCTH
DELCATH SYSTEMS INC
$395.27M0.50%0.50%1.71%2.70%0.1111.2486.00%0.60%2.16%
VREX
VAREX IMAGING CORP
$426.47M-17.60%-7.60%-3.52%-3.30%1.273.2033.60%-9.60%-3.67%
ASTH
ASTRANA HEALTH INC
$2.08B3.90%1.50%6.67%11.20%2.231.3510.70%0.90%3.05%
SEPN
SEPTERNA INC
$1.26B-9.40%-6.60%-7.26%-10.80%0.514.71100.00%-49.90%-49.40%
PTCT
PTC THERAPEUTICS INC
$5.79BN/A-6.80%-3.52%-6.70%-16.902.4492.50%-22.60%-8.28%
UTMD
UTAH MEDICAL PRODUCTS INC
$206.93M9.10%8.90%11.11%68.10%0.0328.6457.90%28.90%35.79%
MDLN
MEDLINE INC
$48.74BN/AN/AN/AN/A1.754.41N/AN/AN/A
HUM
HUMANA INC
$36.46B6.20%2.20%6.02%6.40%1.971.7714.00%0.80%1.48%
CAI
CARIS LIFE SCIENCES INC
$4.51B-78.30%-38.90%8.91%17.10%0.967.0568.70%-45.30%10.00%
AMPH
AMPHASTAR PHARMACEUTICALS INC
$800.73M10.20%4.80%8.67%9.40%1.133.8547.30%11.00%17.84%
RVTY
REVVITY INC
$10.64B3.30%2.00%3.35%8.10%0.671.7254.30%8.30%12.43%
INSM
INSMED INC
$23.74B-130.10%-51.60%-63.90%-62.60%1.954.4781.80%-144.40%-133.71%
EBS
EMERGENT BIOSOLUTIONS INC
$431.86M-1.60%-0.60%5.04%5.00%1.524.2954.20%-1.30%8.73%
BDSX
BIODESIX INC
$153.45M-2,101.40%-35.60%-29.88%-22.60%9.362.8282.10%-33.30%-24.92%
GERN
GERON CORP
$808.32M-28.00%-12.10%-7.75%-5.50%1.336.7897.30%-34.30%-18.21%
CBIO
CRESCENT BIOPHARMA INC
$557.78M-100.90%-88.20%-85.98%1,853.70%0.0813.78100.00%-1,494.60%-1,466.29%
STVN
STEVANATO GROUP SPA
$5.41B9.70%5.70%10.63%9.70%0.691.6329.00%11.70%17.87%
EOLS
EVOLUS INC
$424.76MN/A-19.40%-15.27%-12.20%-8.672.0466.10%-14.40%-7.72%
NUVB
NUVATION BIO INC
$1.67B-44.10%-23.80%-23.68%-21.70%0.917.4490.80%-102.10%-87.84%
UNH
UNITEDHEALTH GROUP INC
$347.35B12.60%3.90%8.94%15.00%2.120.8018.80%2.70%3.95%
ANGO
ANGIODYNAMICS INC
$494.17M-17.60%-11.70%-16.52%-36.80%0.502.3554.30%-10.00%-10.25%
PRPO
PRECIPIO INC
$43.90M-6.70%-4.50%-5.06%-13.10%0.471.5643.70%-3.60%-3.33%
TECH
BIO-TECHNE CORP
$7.42B5.50%4.30%6.49%12.30%0.224.4965.00%9.00%12.86%
PHAR
PHARMING GROUP NV
$898.85M4.70%2.60%5.31%7.80%0.822.6388.10%3.30%5.42%
KYMR
KYMERA THERAPEUTICS INC
$6.63B-25.00%-22.30%-19.59%-26.80%0.0810.81100.00%-612.00%-611.26%
TKNO
ALPHA TEKNOVA INC
$207.49M-24.30%-16.30%-17.76%-14.80%0.524.5934.00%-41.10%-39.00%
IFRX
INFLARX NV
$178.56M-94.90%-70.70%-114.27%-126.30%0.334.16-24,646.30%-146,303.90%-146,091.95%
OPCH
OPTION CARE HEALTH INC
$3.38B15.30%6.00%12.64%16.40%1.501.6419.20%3.60%5.91%
KZIA
KAZIA THERAPEUTICS LTD
$746.48M-217.80%-51.20%-52.23%207.80%0.532.87100.00%-1,200.90%-1,285.72%
SIBN
SI-BONE INC
$656.81M-9.60%-7.10%-6.39%-6.50%0.369.9979.60%-8.10%-6.86%
EVH
EVOLENT HEALTH INC
$431.93M-83.70%-24.60%-31.01%-44.80%3.741.3220.20%-28.30%-24.59%
HTFL
HEARTFLOW INC
$2.52BN/A-36.40%-33.27%-44.50%0.205.5778.10%-58.40%-53.18%
ACH
ACCENDRA HEALTH INC
$207.54MN/A-33.10%-80.33%-48.10%-6.200.4946.00%-39.80%-35.87%
ALEC
ALECTOR INC
$245.37M-295.20%-40.90%-62.94%-60.60%22.115.25100.00%-680.80%-679.92%
XRAY
DENTSPLY SIRONA INC
$1.99B-41.20%-11.20%-11.93%-11.60%2.971.5348.90%-17.10%-13.04%
FMS
FRESENIUS MEDICAL CARE AG
$12.15B7.20%3.00%6.59%7.60%1.301.2126.00%4.90%8.42%
ADMA
ADMA BIOLOGICS INC
$1.96B39.00%27.40%36.10%39.40%0.706.9561.30%32.40%41.89%
SLS
SELLAS LIFE SCIENCES GROUP INC
$1.41B-47.10%-42.60%-27.35%4,971.60%0.0617.22N/AN/AN/A
SOLV
SOLVENTUM CORP
$13.29B30.70%10.00%18.57%23.70%1.841.0753.70%17.30%24.16%
NAMS
NEWAMSTERDAM PHARMA CO NV
$4.18B-29.80%-27.40%-31.98%-106.30%0.109.76100.00%-942.80%-942.76%
UTHR
UNITED THERAPEUTICS CORP
$24.02B19.20%17.20%26.58%30.40%0.144.7986.60%40.60%51.27%
PHR
PHREESIA INC
$533.50M0.70%0.50%-0.41%-2.00%0.971.5367.90%0.50%-0.41%
ROIV
ROIVANT SCIENCES LTD
$22.21B-6.90%-5.70%-3.07%-4.30%0.0918.3784.40%-3,629.20%-2,015.04%
ZTS
ZOETIS INC
$33.57B62.40%17.50%27.01%23.40%3.693.1571.80%27.80%37.21%
MYGN
MYRIAD GENETICS INC
$369.29M-109.10%-57.40%-71.02%-94.50%1.002.4070.00%-48.20%-46.56%
BFLY
BUTTERFLY NETWORK INC
$1.17B-36.80%-25.60%-32.80%-69.60%0.504.0349.20%-73.60%-72.15%
JANX
JANUX THERAPEUTICS INC
$878.78M-11.80%-11.20%-11.81%-11.90%0.0917.01100.00%-833.60%-833.60%
OFIX
ORTHOFIX MEDICAL INC
$420.79M-13.40%-7.00%-5.63%-7.70%1.042.8770.70%-7.30%-4.95%
MMED
MINIMED GROUP INC
$3.29BN/AN/AN/AN/A0.251.59N/AN/AN/A
ELVN
ENLIVEN THERAPEUTICS INC
$2.57B-21.00%-20.40%-21.79%-27.70%0.0340.32N/AN/AN/A
ARDX
ARDELYX INC
$1.57B-38.10%-11.90%-9.22%-6.60%2.403.4992.50%-13.60%-8.52%
BDX
BECTON DICKINSON & CO
$40.30B4.50%2.10%4.68%7.10%1.110.9446.80%5.30%9.27%
DTIL
PRECISION BIOSCIENCES INC
$184.49M-79.60%-34.80%-31.01%-113.80%0.8914.02100.00%-96.70%-93.67%
AVTX
AVALO THERAPEUTICS INC
$872.59M-97.50%-72.40%-95.79%-123.50%0.467.66100.00%-143,627.10%-143,340.68%
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
$2.22B-24.30%-9.90%-9.05%-8.60%1.303.3575.30%-16.80%-12.84%
GDRX
GOODRX HOLDINGS INC
$867.01M3.30%1.40%7.51%10.70%2.251.4791.80%2.60%11.07%
AMWL
AMERICAN WELL CORP
$119.13M-35.10%-25.10%-36.25%-2,146.30%0.383.0952.90%-37.00%-36.99%
RMTI
ROCKWELL MEDICAL INC
$31.97M-15.40%-9.60%-8.99%-11.40%0.603.7417.10%-8.00%-6.32%
NTRA
NATERA INC
$29.17B-15.10%-10.50%-13.72%-48.50%0.472.9665.10%-9.00%-11.28%
ADAG
ADAGENE INC
$179.59M-41.00%-21.00%-32.86%113.30%0.753.07100.00%-229.60%-227.41%
HRMY
HARMONY BIOSCIENCES HOLDINGS INC
$1.77B17.20%12.00%20.07%48.50%0.403.5876.50%16.20%23.54%
NAGE
NIAGEN BIOSCIENCE INC
$301.85M25.40%18.20%21.52%118.30%0.394.6164.30%14.30%15.10%
HYPR
HYPERFINE INC
$148.91M-101.30%-68.80%-69.14%-274.80%0.765.5251.20%-226.90%-226.34%
ICLR
ICON PLC
$8.90B6.30%3.60%6.18%18.50%0.771.0628.10%7.40%10.13%
AZTA
AZENTA INC
$900.65M-10.70%-8.80%-13.25%-28.40%0.232.8343.80%-29.90%-36.60%
AQST
AQUESTIVE THERAPEUTICS INC
$530.65MN/A-49.30%-47.68%-39.50%-5.144.1063.50%-137.10%-103.74%
SLGL
SOL-GEL TECHNOLOGIES LTD
$190.32M-23.70%-18.60%-25.80%-47.00%0.314.37100.00%-31.60%-31.60%
GH
GUARDANT HEALTH INC
$15.65BN/A-26.50%-26.49%-21.00%-11.584.6864.90%-40.10%-39.80%
UFPT
UFP TECHNOLOGIES INC
$1.75B16.60%10.50%15.49%23.90%0.542.9128.40%11.30%15.20%
PLYX
POLARYX THERAPEUTICS INC
$186.53MN/AN/AN/AN/A0.413.45N/AN/AN/A
HSDT
SOLANA CO
$137.79M-155.30%-55.40%-68.83%-65.20%0.019.9094.20%-1,427.10%-1,420.59%
ABT
ABBOTT LABORATORIES
$152.88B12.10%6.90%9.42%17.00%1.101.3956.30%13.90%19.22%
SGRY
SURGERY PARTNERS INC
$1.74B-4.40%-0.90%2.95%3.70%2.931.8622.80%-2.30%6.59%
NRXP
NRX PHARMACEUTICALS INC
$110.86MN/A-219.60%178.08%94.30%-1.860.2950.50%-1,070.30%-1,030.83%
SDEV
STABLECOIN DEVELOPMENT CORP
$40.13M-284.40%-172.80%-46.88%-206.10%0.305.33N/AN/AN/A
TNDM
TANDEM DIABETES CARE INC
$1.08B-68.30%-10.00%-9.92%-8.10%7.713.5854.90%-9.20%-8.74%
TBPH
THERAVANCE BIOPHARMA INC
$842.38M43.80%25.50%31.49%62.00%0.6313.14100.00%104.30%126.38%
TGTX
TG THERAPEUTICS INC
$6.01B87.40%42.80%11.17%13.50%1.625.8183.10%66.00%21.41%
QGEN
QIAGEN NV
$7.22B11.30%6.60%9.31%15.40%0.743.2262.00%19.20%23.52%
ACIU
AC IMMUNE SA
$289.97M-124.00%-40.50%-146.14%1,976.70%3.360.87100.00%-1,788.80%-1,783.31%
SLN
SILENCE THERAPEUTICS PLC
$306.25MN/A-53.70%-71.69%-94.10%-1.339.8379.50%-8,943.90%-8,942.55%
INMD
INMODE LTD
$876.84M13.30%11.80%15.18%26.70%0.148.8077.80%23.30%27.28%
SPTX
SEAPORT THERAPEUTICS INC
N/AN/AN/A-31.37%N/A-0.1817.46N/AN/AN/A
LGND
LIGAND PHARMACEUTICALS INC
$4.45B16.20%11.10%12.77%15.60%0.5421.2895.30%55.90%69.40%
BDMD
BAIRD MEDICAL INVESTMENT HOLDINGS LTD
$67.21M-76.80%-36.90%-67.96%-43.30%1.231.7083.80%-121.00%-112.59%

Healthcare Industries

IndustryStocks1d %1w %1m %1y %DD ScoreP/E ratioP/B RatioROEROAROCEUpside/DownsideConsensus
602+0.98%-2.57%-1.90%-76.05%18.28x4.87x-122.61%-12.79%-9.65%+63.30%Strong Buy
55+0.67%+2.81%-8.17%+10.83%15.48x3.33x-6.63%+6.21%+12.47%+27.83%Strong Buy
20+1.56%+1.86%+5.32%+34.81%35.69x7.08x+34.51%+12.30%+21.70%+16.21%Buy
75+1.45%+0.08%-0.21%-29.54%10.90x1.56x+9.35%+5.09%+10.99%+40.37%Buy
10-0.67%-2.56%+17.39%-0.56%26.31x2.31x+9.02%+2.82%+6.93%+0.78%Buy
53-0.32%+2.09%+1.61%-27.61%18.03x2.95x-3.94%+0.71%+1.12%+39.60%Buy
50-0.91%-2.48%+4.38%-21.64%15.15x4.82x-49.93%+6.78%+15.36%+22.72%Buy
139+0.14%+3.57%-2.51%-69.30%23.09x3.04x+6.44%+5.41%+9.00%+33.12%Strong Buy
10+1.07%+2.30%-9.07%+5.35%22.37x143.42x-104.83%+3.78%+25.68%+28.40%Buy
55+0.20%+3.38%-1.50%-5.73%42.68x3.27x+7.01%+7.29%+10.77%+27.03%Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in May 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Bioventus (NASDAQ:BVS)


Bioventus (NASDAQ:BVS) is the #1 top healthcare stock out of 1069 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Bioventus (NASDAQ:BVS) is: Value: A, Growth: A, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: C.

Bioventus (NASDAQ:BVS) has a Due Diligence Score of 47, which is 20 points higher than the healthcare sector average of 27. It passed 15 out of 33 due diligence checks and has strong fundamentals. Bioventus has seen its stock return 42.55% over the past year, overperforming other healthcare stocks by 102 percentage points.

Bioventus has an average 1 year price target of $15.00, an upside of 57.98% from Bioventus's current stock price of $9.50.

Bioventus stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Bioventus, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)


Jazz Pharmaceuticals (NASDAQ:JAZZ) is the #2 top healthcare stock out of 1069 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Jazz Pharmaceuticals (NASDAQ:JAZZ) is: Value: A, Growth: A, Momentum: B, Sentiment: C, Safety: C, Financials: B, and AI: C.

Jazz Pharmaceuticals (NASDAQ:JAZZ) has a Due Diligence Score of 34, which is 7 points higher than the healthcare sector average of 27. It passed 11 out of 33 due diligence checks and has average fundamentals. Jazz Pharmaceuticals has seen its stock return 122.45% over the past year, overperforming other healthcare stocks by 181 percentage points.

Jazz Pharmaceuticals has an average 1 year price target of $251.09, an upside of 4.88% from Jazz Pharmaceuticals's current stock price of $239.40.

Jazz Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 11 analysts covering Jazz Pharmaceuticals, 72.73% have issued a Strong Buy rating, 27.27% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Indivior Pharmaceuticals (NASDAQ:INDV)


Indivior Pharmaceuticals (NASDAQ:INDV) is the #3 top healthcare stock out of 1069 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Indivior Pharmaceuticals (NASDAQ:INDV) is: Value: B, Growth: B, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: C.

Indivior Pharmaceuticals (NASDAQ:INDV) has a Due Diligence Score of 41, which is 14 points higher than the healthcare sector average of 27. It passed 14 out of 33 due diligence checks and has strong fundamentals. Indivior Pharmaceuticals has seen its stock return 234.79% over the past year, overperforming other healthcare stocks by 294 percentage points.

Indivior Pharmaceuticals has an average 1 year price target of $48.00, an upside of 28.14% from Indivior Pharmaceuticals's current stock price of $37.46.

Indivior Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Indivior Pharmaceuticals, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 75 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Cryo Cell International (NYSEMKT:CCEL)


Cryo Cell International (NYSEMKT:CCEL) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 2.66%.

Cryo Cell International's dividend payout ratio of -45.5% indicates that its dividend yield might not be sustainable for the long-term.

2. So Young International (NASDAQ:SY)


So Young International (NASDAQ:SY) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 2.66%.

So Young International's dividend payout ratio of 0% indicates that its dividend yield might not be sustainable for the long-term.

3. Dominari Holdings (NASDAQ:DOMH)


Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 30.19%, which is 28 percentage points higher than the healthcare sector average of 2.66%.

Dominari Holdings's dividend payout ratio of -19.1% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 0.58% in the last day, and up 0.01% over the last week. Akari Therapeutics was the among the top gainers in the healthcare sector, gaining 255.45% yesterday.

Akari Therapeutics shares are trading higher after the company announced preclinical data demonstrating synergistic activity of AKTX-101 with KRAS inhibition in KRAS-mutated pancreatic cancer models

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Embecta (NASDAQ:EMBC)


Embecta (NASDAQ:EMBC) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 57, which is 42 points higher than the healthcare sector average of 15. It passed 4 out of 7 valuation due diligence checks.

Embecta's stock has dropped -68.4% in the past year. It has underperformed other stocks in the healthcare sector by -9 percentage points.

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)


Ironwood Pharmaceuticals (NASDAQ:IRWD) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ironwood Pharmaceuticals has a valuation score of 86, which is 71 points higher than the healthcare sector average of 15. It passed 6 out of 7 valuation due diligence checks.

Ironwood Pharmaceuticals's stock has gained 532.26% in the past year. It has overperformed other stocks in the healthcare sector by 591 percentage points.

3. Auna Sa (NYSE:AUNA)


Auna Sa (NYSE:AUNA) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Auna Sa has a valuation score of 43, which is 28 points higher than the healthcare sector average of 15. It passed 3 out of 7 valuation due diligence checks.

Auna Sa's stock has dropped -36.8% in the past year. It has overperformed other stocks in the healthcare sector by 22 percentage points.

Are healthcare stocks a good buy now?

60.49% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 39.89% over the next year.

4.95% of healthcare stocks have a Zen Rating of A (Strong Buy), 12.38% of healthcare stocks are rated B (Buy), 48.14% are rated C (Hold), 27.48% are rated D (Sell), and 7.05% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 27.77x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.